|
Volumn 24, Issue 1 SUPPL. 2, 1997, Pages
|
Phase I trial of dose-escalated paclitaxel and carboplatin in combination with ifosfamide and filgrastim: Preliminary results
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CARBOPLATIN;
IFOSFAMIDE;
MESNA;
PACLITAXEL;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
ANTINEOPLASTIC AGENT;
ADULT;
AGED;
ANGIOIMMUNOBLASTIC LYMPHADENOPATHY;
AREA UNDER THE CURVE;
BOLUS INJECTION;
BONE MARROW TOXICITY;
BREAST CANCER;
CANCER COMBINATION CHEMOTHERAPY;
CLINICAL ARTICLE;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CONFERENCE PAPER;
DOSE RESPONSE;
DRUG FEVER;
FEMALE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
KIDNEY TUBULE ACIDOSIS;
LUNG NON SMALL CELL CANCER;
MALE;
MESOTHELIOMA;
METASTASIS;
NAUSEA;
NEUROTOXICITY;
NEUTROPENIA;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
PROSTATE CANCER;
SUBCUTANEOUS DRUG ADMINISTRATION;
VOMITING;
ADENOCARCINOMA;
ARTICLE;
BREAST TUMOR;
DRUG ADMINISTRATION;
IMMUNOBLASTIC LYMPHADENOPATHY;
LUNG TUMOR;
PROSTATE TUMOR;
ADENOCARCINOMA;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CARBOPLATIN;
CARCINOMA, NON-SMALL-CELL LUNG;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
FILGRASTIM;
HUMANS;
IFOSFAMIDE;
IMMUNOBLASTIC LYMPHADENOPATHY;
LUNG NEOPLASMS;
MALE;
MESOTHELIOMA;
PACLITAXEL;
PROSTATIC NEOPLASMS;
|
EID: 0031068410
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (4)
|
References (2)
|